MENLO PARK and SAN DIEGO – MARCH 3, 2014 – PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines, today announced the expansion of its commercial leadership team, including appointments of: Linda Rubinstein as Chief Financial Officer; Piers Whitehead as Chief Corporate Development Officer; and Thomas Yonker as Vice President of Project Management.
to Better the World
Innovative. Beneficial. Simple.
Our mission is to develop and commercialize innovative vaccines against infectious diseases in a socially responsible manner.